Try
IRADIMED CORP
IRMDUnited States
98 filed reports · 365 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
98 reports · Jun 2014 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 510 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 48 | 382 | Jun 2014 to Mar 2026 |
| Quarterly · 10-QSEC EDGAR | 37 | 5,336 | Jun 2014 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 12 | 3,649 | Dec 2014 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 1 | 291 | Dec 2024 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 31, 2026 | 298 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 1, 2026 | 8 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 1, 2026 | 177 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 6, 2026 | 452 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 10, 2026 | 8 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 3, 2025 | 8 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 3, 2025 | 215 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 1, 2025 | 8 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 1, 2025 | 130 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 5, 2025 | 8 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 5, 2025 | 137 | Open |
| FY2024 | 10-K/A | Dec 31, 2024 | Sep 3, 2025 | 291 | Open |
Financial data
365 concepts · 9,658 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial353 concepts · 8,803 facts · Mar 2013 to Jul 2026
- Allocated share based compensation expense66 · Jun 2013 to Jun 2026
- Amortization of intangible assets66 · Jun 2013 to Jun 2026
- Cash and cash equivalents at carrying value66 · Jun 2013 to Jun 2026
- Cost of revenue (US GAAP)66 · Jun 2013 to Jun 2026
- Depreciation66 · Jun 2013 to Jun 2026
- General and administrative expense (US GAAP)66 · Jun 2013 to Jun 2026
- Gross profit (US GAAP)66 · Jun 2013 to Jun 2026
- Income tax expense benefit66 · Jun 2013 to Jun 2026
- Net income loss66 · Jun 2013 to Jun 2026
- Nonoperating income expense66 · Jun 2013 to Jun 2026
- Operating expenses (US GAAP)66 · Jun 2013 to Jun 2026
- Operating income loss66 · Jun 2013 to Jun 2026
- Research and development expense66 · Jun 2013 to Jun 2026
- Revenue66 · Jun 2013 to Jun 2026
- Selling and marketing expense (US GAAP)66 · Jun 2013 to Jun 2026
- Depreciation depletion and amortization65 · Sep 2013 to Jun 2026
- Increase decrease in accounts payable65 · Sep 2013 to Jun 2026
- Increase decrease in accounts receivable65 · Sep 2013 to Jun 2026
- Increase decrease in deferred income taxes65 · Sep 2013 to Jun 2026
- Increase decrease in employee related liabilities65 · Sep 2013 to Jun 2026
- Increase decrease in inventories65 · Sep 2013 to Jun 2026
- Increase decrease in other operating assets65 · Sep 2013 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets65 · Sep 2013 to Jun 2026
- Increase decrease in property and other taxes payable65 · Sep 2013 to Jun 2026
Guidance4 concepts · 382 facts · Aug 2014 to May 2026
- EPS (Diluted) Guidance188 · Aug 2014 to May 2026
- Revenue Guidance188 · Aug 2014 to May 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))4 · Nov 2022
- Revenue Growth Guidance2 · Feb 2015
Geography4 concepts · 247 facts · Jun 2013 to Jun 2026
- Revenue148 · Jun 2013 to Jun 2026
- Property, Plant & Equipment, Net97 · Dec 2016 to Jun 2026
- Gross accounts receivable1 · Dec 2013
- MRI compatible IV infusion pumps1 · Dec 2013
Product4 concepts · 226 facts · Jun 2013 to Jun 2026
- MRI Compatible Intravenous ("IV") Infusion Pump Systems124 · Dec 2016 to Dec 2025
- Revenue97 · Jun 2013 to Jun 2026
- MRI compatible IV infusion pumps4 · Sep 2013 to Jun 2014
- Gross accounts receivable1 · Sep 2013
Segments
473 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis9 members · 146 facts
- MRI Compatible IV Infusion Pumps49 · Dec 2016 to Jun 2026
- MRI Compatible Patient Vital Signs Monitoring Systems34 · Dec 2019 to Jun 2026
- Ferro Magnetic Detection Systems22 · Sep 2022 to Jun 2026
- Mri Compatible Patient Vital Signs Monitoring Systems21 · Dec 2016 to Mar 2021
- Amortized Revenue4 · Mar 2025 to Jun 2026
- Device Revenue4 · Mar 2025 to Jun 2026
- Devices4 · Jun 2017 to Sep 2018
- Disposable Revenue4 · Mar 2025 to Jun 2026
- Service4 · Mar 2025 to Jun 2026
Statement geographicalsrt:StatementGeographicalAxis6 members · 145 facts
- US43 · Dec 2016 to Jun 2026
- International41 · Dec 2016 to Jun 2025
- Us40 · Dec 2017 to Jun 2026
- Non Us10 · Sep 2024 to Jun 2026
- Non us7 · Dec 2024 to Jun 2026
- United States4 · Jun 2017 to Sep 2018
Statement geographicalus-gaap:StatementGeographicalAxis5 members · 102 facts
- International42 · Dec 2016 to Jun 2025
- International25 · Jun 2013 to Mar 2018
- United States25 · Jun 2013 to Mar 2018
- United states8 · Dec 2016 to Sep 2018
- Saudi Arabia2 · Dec 2013
Product or serviceus-gaap:ProductOrServiceAxis4 members · 80 facts
- Devices26 · Jun 2013 to Mar 2018
- Disposable IV Sets And Services24 · Jun 2013 to Dec 2017
- MRI Compatible IV Infusion Pumps19 · Sep 2013 to Mar 2018
- Mri Compatible Patient Vital Signs Monitoring Systems11 · Dec 2015 to Mar 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.